Antibodies to eb virus capsid antigen and to soluble antigen of lymphoblastoid cells in infectious mononucleosis patients
✍ Scribed by Vladimír Vonka; Ivana Vlčková; Hana Závadová; Karel Kouba; Jana Lazovská; Josef Duben
- Publisher
- John Wiley and Sons
- Year
- 1972
- Tongue
- French
- Weight
- 477 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Sera from infectious mononucleosis patients aged 2 to 35 years and from normal subjects aged 11 to 35 years were examined for the presence of antibody to the EB virus capsid antigen (VCA) in the indirect immunofluorescence test, and for the presence of antibody reactive with the soluble (S) antigen of lymphoblastoid cell lines in the complement‐fixation test. Sera from all infectious mononucleosis patients taken either in the acute stage of the disease or up to 9 years after its onset contained VCA antibody. The sera taken in the acute stage of the disease were free of S antibody; out of 97 sera investigated only one was weakly reactive. Only one of the seven sera taken 4 to 5 months after the onset of the disease contained S antibody. After the 7th month following onset, the majority of the subjects possessed S antibody. These data indicate that the S antibody appears much later in the course of EB virus infection than the VCA antibody. The predominant majority of sera from subjects with no history of the disease possessed VCA antibody; most of these also possessed S antibody. The incidence of S antibody in these subjects and those who had been suffering from infectious mononucleosis 1 to 9 years previously were comparable.
📜 SIMILAR VOLUMES
The incidence of antibodies to Epstein-Barr nucleair antigen type 2 (EBNA-2) was determined in sera from rheumatoid arthritis (RA) patients and control subjects, by protein immunoblotting. Sixty-eight percent of the RA patients and 48% of the controls possessed anti-EBNA-2 antibodies. The titer of a
The prevalence of adult T-cell-leukemia virus (ATLV) infection was examined in Japanese monkeys living naturally in various parts of Japan and in other species of non-human primates imported into and kept in Japan. Sera of 2,650 Japanese monkeys from 41 troops throughout Japan were tested. High inci
IgG and IgA antibodies to Epstein-Barr virus (EBV) membrane antigen (MA) were detected in sera from 96 NPC patients and normal individuals by the indirect immunofluorescence test. For MA/IgG antibody, 100% of NPC patients were positive with a GMT of 1:439.7 and 97.9% of normal individuals were posit